You need to be logged in to view this video

MYOV and Other Q4 Biotech Catalysts

Released on Wednesday, October 12, 2022BIOTECH
John McCamant, editor of the Medical Technology Stock Letter, says he expects a bidding war for MYOV and important catalysts from MDGL, TCRT, and PGEN in Q4.


John McCamant
Medical Technology Stock Letter, Editor

Trending Now


Filter By Category
Filter By Keywords
Loading...